Skip to main content

Barcelona equips itself with a European first-class collaborative microscopy platform through the joint action of nine research institutions and the support of ERDF



Press & Communications Section Head
Tel.+34 93 40 37255

The ALBA Synchrotron will host two new major experimental facilities, one dedicated to materials science, valued at 4.1 million euros and led by the Catalan Institute of Nanoscience and Nanotechnology (ICN2), and another meant for molecular biology, valued at 1.7 million euros and headed by the Institute of Molecular Biology of Barcelona (IBMB-CSIC).

The new platform also counts with the participation of the Barcelona Institute of Science and Technology (BIST), the Spanish Council for Scientific Research (CSIC), the Institute for Biomedical Research (IRB Barcelona), the Autonomous University of Barcelona (UAB), the Institute of Materials Science of Barcelona (ICMAB-CSIC) and the Centre for Genomic Regulation (CRG).

Today, the approval of the co-financing through the European Regional Development Fund (ERDF) of these two projects, which involve numerous institutions and research centres, has been made public.


Barcelona, ​​9th April, 2020. Today it has been announced the resolution of the last call for co-funding through the European Regional Development Fund (ERDF) of cooperative projects oriented at creating, building, acquiring and improving shared scientific and technological equipment and platforms. Among the approved strategic projects are two proposals, one led by the Catalan Institute of Nanoscience and Nanotechnology (ICN2) and the other by the Institute of Molecular Biology of Barcelona (IBMB-CSIC), which, thanks to the joint effort of nine research entities, will allow the installation of advanced electron microscopy equipment at the ALBA Synchrotron. This will make Barcelona a hub of excellence in Europe for scientific collaboration in this field.

The ERDF funds, granted by the Secretariat of University and Research of the Department of Business and Knowledge of the Generalitat of Catalonia (Catalan government), aims to provide the scientific community with equipment and platforms that enhance scientific and technological excellence, in particular those related to the transversal key enabling technologies included in the Research and Innovation Strategy for the Smart Specialisation of Catalonia (RIS3CAT). The contribution from European funds reaches up to 50 % of the total cost of their implementation.

The proposal led by the ICN2, which will cost approximately 4.1 million euros, is focused on acquiring and installing advanced equipment for electron microscopy and sample preparation especially designed for materials science and atomic-scale studies. This new installation consists of a Monochromated Transmission Electron Microscope with Aberration Correctors, which will be installed at the ALBA Synchrotron premises, and Focused Ion Beam (FIB) instrumentation to cut the samples in very thin layers and study them with atomic resolution, which will be installed at the ICN2. The realization of this project will be possible thanks not only to the ERDF grants, the "Severo Ochoa Centers of Excellence" ICN2 funds (SEV-2017-0706) and the ALBA Synchrotron investment, but also to the support of the CSIC, the Institute of Materials Science of Barcelona (ICMAB-CSIC) and the Autonomous University of Barcelona (UAB), as well as private donations from the Barcelona Institute of Science and Technology (BIST) —which is formed by institutions such as the ICN2, the CRG and the IRB Barcelona, and which in 2016 promoted the collaborations that have made this new platform possible— and Microsoft. The ICN2 and Microsoft are currently collaborating on the design of hybrid nanowire-based networks and circuits for quantum computers.

On the other hand, the project led by the IBMB-CSIC, valued at about 1.7 million euros, has the purpose of purchasing a high-voltage cryo-electron microscope for biological applications. This type of equipment allows observing the structure of biomolecules at atomic scale without the need to obtain crystals. It is a microscope suitable for biological sample screening and atomic-level structural data acquisition of large molecular and cellular complexes, e.g.: the external structure of a coronavirus as the one responsible for today’s pandemics COVID-19 or the receptors these viruses use to get into the cells. This acquisition will be possible thanks to the funding from ERDF, the IBMB-CSIC and the ALBA Synchrotron, as well as to the contributions of the Institute for Biomedical Research (IRB Barcelona), the CSIC, the Centre for Genomic Regulation (CRG), the UAB and the BIST.

This cross-cutting initiative perfectly aligns with the worldwide trend of centralizing this kind of equipment near large particle accelerators or synchrotron facilities, with the uniqueness that this new research space will be created inside the ALBA premises. It will be a laboratory complementary to synchrotron-light ALBA beamlines, which will bring great added value for materials science and structural biology. The construction works to accommodate the new equipment are planned to start before the end of the year and it is expected that in about two years the new space will be able to receive the first users and host a constantly updated equipment. The electron microscopy platform will provide new opportunities to both research groups and companies looking for state-of-the-art microscopy equipment.


For further information please contact:


Institut Català de Nanociència i Nanotecnologia (ICN2)

Marketing and Communication Department

Àlex Argemí, Head of Marketing and Communication:; +34 635 861 543


Institut de Biologia Molecular de Barcelona (IBMB-CSIC)

Núria Verdaguer, Directora:; +34 934 034 952


ALBA Synchrotron

Communications & Outreach Office

Laia Torres Aribau:; 93 592 4071






About IRB Barcelona

The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).